Two Mitosis-Specific Antibodies, MPM-2 and Phospho-Histone H3 (Ser28), Allow Rapid and Precise Determination of Mitotic Activity
Authors:
- Heinz KutznerHKHeinz Kutzner
- Thomas MentzelTMThomas Mentzel
- Spasenija SavicSSSpasenija Savic
- Daniel BaumhoerDBDaniel Baumhoer
- Katharina GlatzKGKatharina Glatz
- 1 January 2006
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 30 (1) , 83-89
Abstract
Mitotic figure (MF) counting is important in the evaluation of many tumor types. Inadequate fixation, crush artefacts, the presence of many apoptoses, or the rarity of MFs in a given lesion can make the determination of the mitotic index a very time-consuming or even impossible task, especially for novices. We evaluated the potential of the two commercially available mitotic markers MPM-2 and Phospho-Histone H3 Ser28 (PHH3) for improving mitotic counting. Formalin-fixed tissue of 1 lymphoma, 19 epithelial, 25 mesenchymal, and 10 melanocytic tumors was immunohistochemically stained with both antibodies. Mitotic counts of each tumor sample were determined by a pathologist and three residents in the hematoxylin and eosin and in both immunohistochemical stainings. Because of the higher sensitivity of the immunohistochemical stainings for MFs, average mitotic counts per 10 HPF were higher with MPM-2 (11.0) and PHH3 (10.1) than with hematoxylin and eosin (5.9) staining. The precise distinction of MFs from apoptoses and the visualization of the distribution of MFs uncovering mitotic hotspots, even at low magnification, turned out to be major advantages of both mitotic markers. In addition, the average time needed to establish the mitotic count was reduced by 40.3% with MPM-2 and by 50.4% with PHH3. MPM-2 and PHH3 were subjectively rated by all pathologists involved in this study to be very helpful in mitotic counting, especially in melanocytic and mesenchymal lesions but less so in epithelial tumors. Both markers have hence been successfully introduced in our laboratory for the routine assessment of MFs in melanocytic and mesenchymal tumors.Keywords
This publication has 43 references indexed in Scilit:
- Immunocytochemical assessment of mitotic activity with an antibody to phosphorylated histone H3 in the macaque and human endometriumHuman Reproduction, 2003
- Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanomaCancer, 2003
- Predictive value of grade for metastasis development in the main histologic types of adult soft tissue sarcomasCancer, 2001
- Counting mitoses by image processing in Feulgen stained breast cancer sections: The influence of resolutionCytometry, 1997
- Standardized Mitotic Counts in Breast Cancer Evaluation of the MethodPathology - Research and Practice, 1996
- Estimating mitotic activity in tumoursHistopathology, 1996
- Problematic Uterine Smooth Muscle NeoplasmsAmerican Journal of Surgical Pathology, 1994
- Mitosis counting in tumorsHuman Pathology, 1990
- Reproducibility of a histopathologic grading system for adult soft tissue sarcomaCancer, 1986
- The grading of soft tissue sarcomas results of a clinicohistopathologic correlation in a series of 163 casesCancer, 1984